Skip to content
Disclosery

Founders Fund V Management, LLC

Follow

13F filer, CIK 1697733, SAN FRANCISCO, CA

Founders Fund V Management, LLC reported $571,668 across 4 holdings for the quarter ended 2024-09-30, in a 13F-HR/A filed 2025-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001085146-25-001673

Period
2024-09-30
Reported value
$572K
Holdings
4
Top 10 weight
100%
New
0
Sold out
0

Part of the filer group Founders Fund Growth II Management, LP

How groups are built

Holdings, Q3 2024

Share positions as resolved from 13F-HR/A 0001085146-25-001673, largest first. % of portfolio is the value over $571,668, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CYCLO THERAPEUTICS INCCYCLO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 480,708 shares; 2024Q2: 480,708 shares; 2024Q3: 480,708 shares 480,708$379K66.35%0
UNITY BIOTECHNOLOGY INC COM…UNITY BIOTECHNOLOGY INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 49,172 shares; 2024Q2: 49,172 shares; 2024Q3: 49,172 shares 49,172$72.3K12.64%0
RGTIRIGETTI COMPUTING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 88,621 shares; 2024Q2: 88,621 shares; 2024Q3: 88,621 shares 88,621$69.4K12.14%0Timeline
NTBLQNOTABLE LABS LTD ORD SHSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: 117,924 shares; 2024Q3: 117,924 shares 117,924$50.7K8.87%0Timeline

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-24-005959 superseded2024-11-14acceptance time not in the bulk data set
13F-HR/A 0001085146-25-001673 baserestatement2025-02-14acceptance time not in the bulk data set